ERS Respiratory Channel

CDN Connection Issue

It appears that your current network does not allow connection to the CDN (Content Delivery Network) required for this service to function properly.

To resolve this issue, please try the following actions :

• Contact your network administrator : Inform them of this restriction so they can adjust the network settings accordingly.

• Use another network : Try connecting from a different network, such as another Wi-Fi network or a mobile connection.

We apologize for the inconvenience and thank you for your understanding.

Abstract

Introduction

Pulmonary manifestations of COVID-19 range from asymptomatic cases over severe acute lung injuries such as ARDS to pulmonary long-COVID manifestations. In addition to hyperinflammation, fibrotic lung changes may occur, whose pathogenesis is not yet fully understood.

Aims and objectives

The aim of our pilot study was to characterize differences of fibrosis-associated pathways in patients with acute COVID-19 ARDS and long-COVID-ILD compared to non COVID-19 ARDS and other ILD, respectively.

Methods

We performed comprehensive transcriptome analyses for RNA sequencing (TruSeq-RNA Kit, Fa. Illumina) on 18 formalin-fixed, paraffin-embedded (FFPE) lung samples (autopsy/intraoperative tissue samples, lung biopsies) from patients with COVID-19 ARDS +/- invasive ventilation and long-COVID-ILD compared to 30 control samples from non COVID-ARDS, NSIP, COP, IPF and healthy lung tissue.

Results

In general, transcriptome analyses on FFPE material were challenging due to RNA denaturation. Both homologous and significantly differentially regulated gene expression patterns were identifiable relating to specific fibrosis pathways in COVID-19, non COVID-ARDS, COP and NSIP (see Figure 1).

Conclusions

Our preliminary transcriptome analyses suggest distinct gene expression patterns in the various subgroups and may set the basis for future molecular biological studies to understand specific lung fibrosis pathways.

Abstract

#{title}